சேணோ மருத்துவ கருவிகள் இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சேணோ மருத்துவ கருவிகள் இன்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சேணோ மருத்துவ கருவிகள் இன்க் Today - Breaking & Trending Today

Global Photoacoustic Imaging Market Report 2020-2030: Acquisitions and Mergers Done for the Photoacoustic Imaging Technique Gaining Prominence

Share this article
Share this article
ResearchAndMarkets.com s offering.
The global photoacoustic imaging market reached a valuation of $39.8 million in 2019 and is predicted to generate a revenue of $279.3 million by 2030, progressing at a CAGR of 20.3% between 2020 and 2030.
The increasing incidence of cancer and the rising popularity of advanced medical treatments around the world are the main factors fueling the growth of the market.
The surging geriatric population is another important market growth driver. As per the 2019 World Population Ageing report produced by the UN, the total population of the people in the age bracket- 65 years and above is predicted to rise from 703 million to 1.5 billion from 2019 to 2050. This will massively push up the requirement for photoacoustic imaging as the geriatric people are highly vulnerable to various diseases, on account of their low immunity levels. ....

United States , Laura Wood , Vibronix Inc , Research Scope , Strategic Development Activities Of Key Players , Photosound Technologies Inc , Verasonics Inc , Research Objectives , Visualsonics Inc , Porter Five Forces Analysis , Centers For Disease , Tomowave Laboratories Inc , Office Hours Call , Research Methodology , World Health Organization , Company Profiles , E St Office Hours Call , Sonics Inc , Seno Medical Instruments Inc , Research Background , Photoacoustic Imaging Market Research , Imaging Market Research Report , Imaging Systems , Industry Analysis , Growth Forecast , Population Ageing ,

FDA Approves Seno Medical's Ground-Breaking Breast Cancer Diagnostic Technology

FDA Approves Seno Medical s Ground-Breaking Breast Cancer Diagnostic Technology
Seno s Imagio Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using a novel combination of ultrasound and opto-acoustic technology.
San Antonio, TX, Jan. 19, 2021 (GLOBE NEWSWIRE) The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based
Seno Medical Instruments, Inc. (Seno)
premarket approval (PMA) for its groundbreaking
diagnostic breast cancer imaging technology that helps physicians better differentiate between benign and malignant breast lesions. The company s Imagio
Breast Imaging System uses non-invasive opto-acoustic ultrasound (OA/US) technology to provide information on suspicious breast lesions in real time, helping providers characterize and differentiate masses that may - or may not - require more invasive diagnostic evaluation. ....

United States , San Antonio , Seno Imagio , Kostenloser Wertpapierhandel , A Thomas Stavros , Radiological Health , Us Food Drug Administration , Seno Medical Instruments Inc , Outcomes Research , Imagio Breast Imaging System , Drug Administration , Texas Based Seno Medical Instruments , Imaging System , Chief Executive Officer Tom Umbel , Chief Medical Officer , Medical Instruments , Utilization Patterns , Associated Costs , Breast Imaging , Diagnostic Procedures After Screening , Medi Cal , ஒன்றுபட்டது மாநிலங்களில் , சான் அன்டோனியோ , கதிரியக்கவியல் ஆரோக்கியம் , சேணோ மருத்துவ கருவிகள் இன்க் , ஔட்கம்ஸ் ஆராய்ச்சி ,

Investegate |Seno Medical Announcements | Seno Medical: FDA Approves Seno Medical's Ground-Breaking Breast Cancer Diagnostic Technology

FDA Approves Seno Medical’s Ground-Breaking Breast Cancer Diagnostic Technology
Seno’s Imagio® Breast Imaging System helps physicians differentiate between benign and malignant breast lesions using a novel combination of ultrasound and opto-acoustic technology.
San Antonio, TX, Jan. 19, 2021 (GLOBE NEWSWIRE) The Center for Devices and Radiological Health (CDRH) of the US Food & Drug Administration (FDA) has granted Texas-based
Seno Medical Instruments, Inc. (Seno)
premarket approval (PMA) for its groundbreaking
diagnostic breast cancer imaging technology that helps physicians better differentiate between benign and malignant breast lesions. The company’s Imagio
® Breast Imaging System uses non-invasive opto-acoustic ultrasound (OA/US) technology to provide information on suspicious breast lesions in real time, helping providers characterize and differentiate masses that may - or may not - require more invasive diagnostic evaluation. ....

United States , San Antonio , Seno Imagio , A Thomas Stavros , Breast Cancer Diagnostic Technology , Radiological Health , Us Food Drug Administration , Seno Medical Instruments Inc , Outcomes Research , Breast Imaging System , Drug Administration , Texas Based Seno Medical Instruments , Seno Medical , Chief Executive Officer Tom Umbel , Chief Medical Officer , Medical Instruments , Utilization Patterns , Associated Costs , Breast Imaging , Diagnostic Procedures After Screening , Investegate Announcements , Investegate Company Announcements , Globe Newswire , Globenewswire And , ஒன்றுபட்டது மாநிலங்களில் , சான் அன்டோனியோ ,

Photoacoustic Imaging Market to $279.3 Million by 2030 says P&S Intelligence

Share this article
Share this article
NEW YORK, Dec. 15, 2020 /PRNewswire/ As per the World Health Organization (WHO), in 2018, 2.09 million cases, 2.08 million cases, 1.80 million cases, 1.28 million cases, 1.04 million cases, and 1.03 million cases of lung cancer, breast cancer, colorectal cancer, prostate cancer, skin cancer, and stomach cancer, respectively, were detected. Due to this factor, the global photoacoustic imaging market will likely witness a healthy 20.3% CAGR during 2020–2030, to grow to $279.3 million by 2030 from $39.8 million in 2019, says P&S Intelligence.
Photoacoustic imaging is used to look at the internal human anatomy, wherein the pictures are formed based on how much laser radiation is being absorbed by tissues or the contrast agent injected. In this regard, the photoacoustic imaging market is also being driven by the increasing prevalence of respiratory and cardiovascular diseases (CVDs). The WHO estimates the annual death count of CVDs ....

United States , Prajneesh Kumar , Tomowave Laboratories Inc , Vibronix Inc , World Health Organization , Sonics Inc , Verasonics Inc , Photosound Technologies Inc , Seno Medical Instruments Inc , Visualsonics Inc , Photoacoustic Imaging Market Research , Photoacoustic Imaging Market Research Report , Imaging Systems , Industry Analysis , Growth Forecast , Innolas Laser Gmbh , Teem Photonics , Thera Medical Gmbh , Global Photoacoustic Imaging Market , Imaging Systems Market , Vitro Diagnostic Market , ஒன்றுபட்டது மாநிலங்களில் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சோனிக்ஸ் இன்க் , சேணோ மருத்துவ கருவிகள் இன்க் , இமேஜிங் அமைப்புகள் ,